Alcohol use disorder relapse factors: A systematic review.
Sliedrecht W, de Waart R, Witkiewitz K, Roozen HG.
Psychiatry Res. 2019 Aug;278:97-115. doi: 10.1016/j.psychres.2019.05.038. Epub 2019 May 25.
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.
Müller J, Cagol A, Lorscheider J, Tsagkas C, Benkert P, Yaldizli Ö, Kuhle J, Derfuss T, Sormani MP, Thompson A, Granziera C, Kappos L.
JAMA Neurol. 2023 Nov 1;80(11):1232-1245. doi: 10.1001/jamaneurol.2023.3331.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Portaccio E, Bellinvia A, Fonderico M, Pastò L, Razzolini L, Totaro R, Spitaleri D, Lugaresi A, Cocco E, Onofrj M, Di Palma F, Patti F, Maimone D, Valentino P, Confalonieri P, Protti A, Sola P, Lus G, Maniscalco GT, Brescia Morra V, Salemi G, Granella F, Pesci I, Bergamaschi R, Aguglia U, Vianello M, Simone M, Lepore V, Iaffaldano P, Filippi M, Trojano M, Amato MP.
Brain. 2022 Aug 27;145(8):2796-2805. doi: 10.1093/brain/awac111.
How patients with multiple sclerosis acquire disability.
Lublin FD, Häring DA, Ganjgahi H, Ocampo A, Hatami F, Čuklina J, Aarden P, Dahlke F, Arnold DL, Wiendl H, Chitnis T, Nichols TE, Kieseier BC, Bermel RA.
Brain. 2022 Sep 14;145(9):3147-3161. doi: 10.1093/brain/awac016.
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.
Kalincik T.
Neuroepidemiology. 2015;44(4):199-214. doi: 10.1159/000382130. Epub 2015 May 20.
Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables.
Bergamaschi L, Chiaravalli S, Livellara V, Sironi G, Puma N, Nigro O, Gattuso G, Luksch R, Terenziani M, Spreafico F, Meazza C, Podda M, Biassoni V, Schiavello E, Hovsepyan S, Morosi C, Vennarini S, Massimino M, Casanova M, Ferrari A.
Pediatr Blood Cancer. 2023 Jan;70(1):e30050. doi: 10.1002/pbc.30050. Epub 2022 Oct 10.
Relapse Risk and Safety of Long-Term Tocilizumab Use Among Patients With Giant Cell Arteritis: A Single-Enterprise Cohort Study.
Samec MJ, Rakholiya J, Langenfeld H, Crowson CS, Abril A, Wang B, Mertz L, Rodriguez-Pla A, Bansal P, Burke M, Jaquith J, Weyand C, Warrington KJ, Koster MJ.
J Rheumatol. 2023 Oct;50(10):1310-1317. doi: 10.3899/jrheum.2022-1214. Epub 2023 Jun 15.
Relapse after allogeneic stem cell transplantation.
Barrett AJ, Battiwalla M.
Expert Rev Hematol. 2010 Aug;3(4):429-41. doi: 10.1586/ehm.10.32.
Acute Multiple Sclerosis Relapse.
Berkovich RR.
Continuum (Minneap Minn). 2016 Jun;22(3):799-814. doi: 10.1212/CON.0000000000000330.
Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.
Doyle AJ, Stubbs MJ, Dutt T, Lester W, Thomas W, van Veen J, Hermans J, Cranfield T, Hill QA, Clark A, Bagot C, Austin S, Westwood JP, Thomas M, Scully M.
Blood. 2023 Jan 19;141(3):285-294. doi: 10.1182/blood.2022017023.
